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Aims: This study examined the perspectives and experiences of patients, parents, and health 
care providers with shared medical appointments (SMAs) for children and adolescents with 
type 1 diabetes. Specifically studied were reasons to attend SMAs, perceived differences 
between SMAs and individual medical appointments, patient-valued health care aspects, and 
providers’ performance.
Methods: Fifty-two patients, 8 parents, and 36 health care providers participated. Perspectives 
on SMAs were assessed with questionnaires and an online focus group. Data was analyzed 
using descriptive statistics.
Results: Health care providers had work-related reasons to conduct SMAs. Patients and  parents 
primarily valued the presence of other patients during SMAs. According to health care providers 
and patients, a higher or similar amount of information was discussed during SMAs as opposed 
to individual appointments, respectively. SMAs did contain more discussion about lifestyle. 
Most consultation aspects considered important by the patients were performed by their health 
care providers. Patient satisfaction with SMAs did tend to decrease after 3 months. Parents were 
somewhat more critical about SMAs.
Conclusions: Health care providers, patients, and parents were generally positive about SMAs. 
Future studies should examine the impact of the presence of parents and different health care 
providers during SMAs, and that of differences in patient age, type of insulin treatment, and 
disease-related problems.
Keywords: child, adolescent, diabetes mellitus type 1, pediatrics, shared medical 
appointment
Introduction
Diabetes is one of the most common childhood chronic diseases in the Netherlands. In 
every 1000 children, 2.2 children have diabetes and 98% suffer from type 1  diabetes.1 
In order to prevent the development and progression of chronic complications, diabetics 
need to maintain their glucose level as close as possible to normal.2 To do so, appro-
priate self-management is essential3 supervised by a diabetes team and the patient’s 
parents.4 Parental involvement appears to be related to a child’s adequate blood glucose 
monitoring.5,6 When reaching adolescence, however, children have to learn to manage 
their diabetes independently.7 Within this context, parents could also gradually stop 
accompanying their child to control visits, to allow the child’s perspective to be heard 
better.8 A shared medical appointment (SMA) may support this process.
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SMAs were introduced in the United States in 1996 
to improve the quality of care as well as patients’ self-
 management skills.9,10 During an SMA, a multidisciplinary 
team provides medical care to a homogenous group of 
patients and this allows plenty of time to go deeper into 
specific topics.11 During SMAs, patients have the  opportunity 
to learn from and share experiences with each other,12 which 
may make them feel less isolated with their chronic disease.9 
An SMA can be provided as a replacement visit or in addition 
to traditional individual control visits.13 SMAs have shown 
to increase quality and outcomes of care, patient education, 
compliance and patient and provider satisfaction. Besides, 
more attention appears to be given to psychosocial needs 
and lifestyle behavior.14 In case of pediatric-patients, parents 
usually accompany their children.
In type 2 diabetes, SMAs seem to lead to lower glyco-
sylated hemoglobin (HbA
1c
) levels, improved self-care and 
adherence to guidelines, better blood glucose monitoring, 
higher self-efficacy, quality of life, diabetes knowledge, and 
satisfaction, and even to reduced cardiovascular risks.15–19 
One study showed that SMAs also led to higher health-related 
quality of life in older adolescents with type 1 diabetes.20 
Besides, compared to individual visits, SMAs appear 
to cover more diabetes-related topics21 and  education.22 
 Apparently, patients with diabetes benefit from SMAs in 
different ways.21 However, findings usually come from small-
scaled studies and do not often incorporate the perspective 
of parents. Also, the evidence from existing literature on 
this topic is small. The objective of the present study was 
to investigate the perspectives and experiences with SMAs 
in different  participants, ie, patients, their parents, and their 
health care providers. To get a comprehensive view on their 
opinions, these were studied using different methodological 
approaches. This triangulation made it possible to compare 
different perspectives,23 and to elicit more complete findings24 
and a better understanding of current SMA practices.25
Methods
Participants
Seven Dutch hospitals agreed to participate in SMAs. A 
total of nine SMAs took place (two hospitals conducted 
two SMAs). Five SMAs were conducted in August and 
September 2008, as part of a previous study by NIVEL21 
and four SMAs took place between September 2010 and 
December 2011 as part of the present study by NIVEL. The 
two studies had identical study designs.12,21 Seven SMAs 
were based on the same intervention protocol,11 and two 
other SMAs focused specifically on alcohol use. During the 
seven protocolized SMAs the health care providers discussed 
patients’ medical progression and related questions one by 
one. About the relationship between alcohol and diabetes, 
professionals provided mainly advice and education. The 
intervention protocol did not change during the two con-
ducted studies.11
Hospitals were located in the west, east and south 
part of the Netherlands. The SMAs were conducted by a 
total of 36 health care providers. Each health care team 
consisted of three to six health care providers such as 
pediatricians, diabetes nurses, and psychologists. One of 
these providers was also the moderator during an SMA 
(see Appendix 1).
Patients were included if they had type 1 diabetes, the 
ability to understand and speak Dutch, were aged between 
6 and 18 years and were scheduled to have an SMA. One or 
two parents (n = 41) per patient were present in six SMAs 
(range 4 to 11 parents), regardless of the patients’ age. 
 However, patients under the age of 12 years (n = 14) were 
always accompanied by their parent(s) during an SMA.
Parents who had previously attended an SMA were asked 
to participate in an online focus group (OFG), by means of 
an information letter with consent form by post or by email, 
to exchange their experiences with SMAs with other parents. 
Nine parents wanted to participate of which eight (seven 
mothers, one father) actually did.
Procedure
SMAs
SMAs are part of usual care in the participating hospitals. 
Researchers were not involved in scheduling this type of 
patient care; they only asked participating patients and pro-
viders to fill in questionnaires and to grant them permission 
to have their SMA recorded on tape.
All SMAs were held in an outpatient setting. Depending 
on the hospital’s current policy, the SMA could either be a 
replacement of a routine, individual 3-monthly follow-up 
visit, or an additional visit to the pediatric ward. SMAs 
were divided into sessions for two different age groups: 
6–12 and 12–18 years. Some groups consisted of patients 
aged between 12 to 15 years and between 15 to 18 years, 
because of the number of patients willing to participate. 
Children and adolescents were given a choice by their 
pediatrician to either participate in the SMA or not. 
Unfortunately, we have no information about the number 
of no-shows. Patient sex, diabetes duration and/or current 
problems of participants were not issues in the construc-
tion of SMA groups.
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Patients and their parents were sent a letter and informed 
consent form before attending an SMA to inform them about 
the study’s purpose and requirements. Before and after 
attending an SMA, and at 3-month follow-up, patients were 
asked to fill in a questionnaire. In case of young children 
(,12 years, n = 14), the child filled in the questionnaires 
together with a parent, who had also attended the SMA. 
A total of 52 children and adolescents attended an SMA 
and filled in the baseline questionnaire. After the SMA, 
46 patients filled in the post-visit questionnaire, and 29 
patients at the 3-month follow-up (see Table 1).
Health care providers also completed a questionnaire 
after the SMA (n = 35). We used identical questionnaires 
for the patients and health care providers as in the previous 
study.12,21
Our research complied with the Helsinki Declaration. 
All patients, parents, and health care providers signed an 
informed consent form before participation. The studies 
were carried out according to Dutch privacy legislation. The 
privacy regulation was approved by the Dutch Data Protec-
tion Authority. According to Dutch legislation, approval by 
a medical ethics committee was not required for this study.
Online focus group
An OFG was conducted to investigate the parents’ 
 perspectives.26 During an OFG, a small number of people are 
asked to discuss a topic and to express their views, allowing for 
frequent and long written reactions and equal  contributions.27 
An OFG is useful for assessing data from people that live 
far away from each other,28 or who would not participate in 
a traditional face-to-face focus group.29 In this study, each 
of the eight participating parents received a login name and 
password enabling them to access the Website of the OFG 
anonymously during one week. The OFG was held asynchro-
nously, ie, the parents were free to log in at any time and any 
place. Parents could post their comments and opinions, and 
read and react to the comments of other parents. They were 
asked to react to five statements: (1) My child can obtain 
more knowledge about coping with diabetes by hearing the 
experiences of other patients; (2) As a parent, I always want 
to be present during an SMA of my child; (3) During an SMA, 
many different health care providers should be present, and 
one of these must be a pediatrician; (4) An SMA must replace 
an individual visit and not be an extra visit next to the regular 
individual appointments; (5) An SMA should become a man-
datory visit in diabetes care. Every morning during the first 
five days, one of these statements was added to the Website. 
During the sixth and seventh day, the OFG remained open 
for reactions. The parents were instructed not to mention any 
names for anonymity purposes. During the OFG, the research-
ers kept track of each posting. Afterwards, all reactions were 
categorized in the same topics to which patients and health 
care providers reacted in the questionnaires.
Questionnaires
Reasons for conducting  
or attending SMAs
Health care providers and patients were asked (at baseline) 
to indicate why they wanted to attend an SMA by ticking any 
of the reasons derived from the previous study.12,21
Opinions about SMAs relative  
to individual visits
To examine differences in receiving information during 
an SMA and an individual visit, patients completed four 
5-point Likert scaled items, ranging from 1 ‘much less’ to 
5 ‘much more’. The health care providers completed the 
same items plus two additional ones after the SMA (post-
visit questionnaires).
Perceived quality of SMAs
Patients and health care providers completed the QUality Of 
care Through patients’ Eyes (QUOTE) scale before (baseline) 
and after the SMA (post-visit questionnaire), to assess the 
issues that participants considered important and performed, 
respectively.30,31 QUOTE items are scored on a 4-point scale, 
from 1 ‘not important/no’ to 4 ‘very important/yes’.  Researchers 
were present when patients filled in the questionnaires to give, 
if necessary, additional information or explanation.
Table 1 Participants and response rates
Instruments used Present/completed by n
Baseline questionnaire Children (8–12 years)
Adolescents (12–18 years)
Children or adolescents*
14
36
2
Nine shared medical  
appointments (SMAs) 
Six (out of nine) SMAs
Children (8–12 years)
Adolescents (12–18 years)
Children or adolescents*
Health care providers
Parents
14
36
2
36
41
Post-questionnaire Children (8–12 years)
Adolescents (12–18 years)
13
31
Children or adolescents*
Health care providers
2
35
Online focus group (OFg) Parents 8
Questionnaire after  
3 months
Children (8–12 years)
Adolescents (12–18 years)
6
23
Note: *Two children/adolescents completed the baseline and post-questionnaire 
(and attended an SMA), but did not fill in their birthday or age.
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Appreciation of SMAs
Patients and health care providers were asked to indicate on 
a 5-point Likert scale how satisfied they were with the SMA 
(post-visit questionnaire and after 3 months), with items from 
1 ‘not satisfied at all’ to 5 ‘completely satisfied’. Patients were 
also asked to express their opinion about nine 5-point Likert 
scale statements regarding SMAs, ranging from ‘completely 
disagree’ to ‘totally agree’.
Analysis
Data were analyzed using SPSS software (v. 18; SPSS 
Inc, Chicago, IL). With the use of descriptive statistics, 
patients’ and health care providers’ perspectives on SMA for 
 children and adolescents with type 1 diabetes were analyzed. 
 Differences between measurements (eg, satisfaction) were 
tested using a paired t-test.
Results
Reasons for participation
Patients’ reasons
Participating patients (26 boys, 26 girls) were between 8 
and 18 years old (mean [M] = 13.08, standard deviation 
[SD] = 2.51). All had Dutch nationality (see Table 1). The 
most often mentioned reason for attending an SMA were 
patients’ expectation to share experiences with (n = 36) 
and to learn from fellow patients (n = 30). Fifteen patients 
mentioned that they attended an SMA to receive more 
information about the disease and treatment and two patients 
wanted to spend more time with the health care providers. 
Ten patients presented other reasons, such as: ‘they asked 
us’, ‘it is planned as my quarterly consultation’, and ‘to make 
friends who have similar experiences’.
Health care providers’ reasons
Most health care providers (n = 32) indicated that they con-
duct an SMA for a variation in their work, to work in a dif-
ferent way with colleagues (n = 24), and to learn something 
new (n = 20). Fourteen providers mentioned other reasons 
such as wanting to learn from patients (n = 5). According 
to the providers, patients react more openly during SMAs 
and thereby facilitate this learning process. Other examples 
of answers to the open question were: ‘to learn from each 
other’, ‘to help more patients in less time’, and ‘to improve 
the quality of care’.
Parents’ reasons
During the OFG, parents (75%) indicated that they stimulate 
their children to participate in an SMA, even when they 
show some resistance. With such an experience, children 
can determine for themselves whether or not SMAs comply 
with their needs and whether they want to attend future 
SMAs. According to the parents (37.5%), SMAs are only 
useful when children act openly and are committed, not when 
SMAs are seen as unpleasant. Children should determine for 
themselves if they want to share their experiences with other 
children. Most parents (87.5%) do not want SMAs to become 
additional visits. As one parent stated: “The less hospital 
visits, the better”. They do consider SMAs valuable as a way 
to improve their child’s understanding of potential future 
problems or complications. Furthermore, parents (37.5%) 
want their child to attend SMAs in order to enhance their 
relationship with other patients with type 1 diabetes. The 
absence of parents during SMAs allows children to interact 
with each other without any interference from parents. One 
parent said: “An SMA provides privacy for children, and they 
will not talk openly about particular topics when (other) 
parents are present”. Most parents (75%) indicated that they 
do not accompany their children to an SMA, like they do to 
an individual visit. Although an SMA is seen as important 
for meeting peers, parents (25%) mentioned that SMAs may 
be more useful for children aged 10 years or older, because 
these children have developed a better empathic ability. For 
adolescents, an SMA can be seen as a step to independence. 
As one parent reacted: “My influence during medical visits 
is gradually decreasing. This is very important”.
SMAs versus individual visits
According to patients and health  
care providers
Most participants felt that children and adolescents with 
type 1 diabetes receive at least as much information about 
diabetes and its treatment during an SMA as during an indi-
vidual medical appointment (Table 2). Forty-two percent 
of the patients and 76% of the health care providers had the 
opinion that more information about lifestyle is discussed 
during an SMA. However, 46.7% of the patients thought 
that the amount of information provided about lifestyle was 
similar to that in an individual visit.
According to parents
During the OFG, parents (50%) mentioned that their children’s 
knowledge increases during SMAs by learning from other 
children. This is especially the case for younger or recently 
diagnosed children, because peers can teach each other skills 
regarding their diabetes management.  Nevertheless, parents 
do appreciate some aspects of individual medical visits more. 
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One parent for instance believes that his/her child receives more 
feedback from health care providers during an individual visit. 
Parents (25%) also value the privacy of an individual visit, par-
ticularly when discussing personal problems. According to an 
equal number of parents, the topics discussed during an indi-
vidual appointment are more tailored to the individual patient. 
If their child experiences unusual problems, these problems are 
more easily addressed during an individual appointment. It is 
important to parents that their children receive sufficient 
individual attention from health care providers during an SMA. 
To some parents (25%), it does not matter how their child 
receives information about diabetes, as long as (s)he does.
Importance and performance  
of consultation aspects
Patients’ needs and health care providers’ 
performance
Before attending the SMA, patients had indicated how 
important they considered nine aspects of health care 
 providers’ consulting behavior. After the SMA, the patients 
rated the degree to which each aspect had been performed 
(Tables 3–5). The ratings revealed that patients value being 
taken seriously and that their health care providers are 
friendly and listen to their concerns. Patients considered most 
of these aspects to be performed during their SMA.
Parents’ perspectives on performance
According to parents (25%), health care providers have super-
vised their children sufficiently during SMAs. The other parents 
(75%) did not comment on the performance by providers during 
SMAs. For the majority of parents (75%), it is important that 
a diabetes nurse and a pediatrician are present during SMAs; 
Table 2 Perspectives on shared medical appointments as opposed 
to individual visits
(Much)  
less
Equal (Much)  
more
n % n % n %
Health care providers
Information about lifestyle 3 12.0 3 12.0 19 76.0
Information about diabetes 3 11.5 8 30.8 15 57.6
Information about treatment 4 15.4 8 30.8 14 53.8
Attention for each patient 5 20.0 7 28.0 13 52.0
Information about insulin 8 30.8 10 38.5 8 30.8
Time per patient 14 53.8 8 30.8 4 15.3
Patients
Information about lifestyle 5 11.1 21 46.7 19 42.2
Information about diabetes 8 17.8 24 53.3 13 28.9
Information about treatment 9 20.0 27 60.0 9 20.0
Information about insulin 12 26.7 27 60.0 6 13.3
Table 3 Percentage of patients that value different consultation 
aspects (n = 52)
For the forthcoming shared  
medical appointment, it is  
important that the health  
care provider…
Importanta Not importantb
n % n %
Examines me 33 63.4 18 36.6
Is friendly 49 94.2 3 5.8
Takes me seriously 51 98.1 1 1.9
Listens to what I have to say 51 98.1 1 1.9
Is open to me 46 90.2 4 7.9
Has enough time for me 48 92.3 4 7.7
Is empathic to me 34 66.6 17 33.3
gives me enough attention 42 80.8 9 17.3
gives good information 48 92.3 4 7.6
Notes: aAspects rated as ‘very important’ or ‘important’ are indicated as important; 
baspects rated as ‘somewhat important’ and ‘not important’ are indicated as not 
important.
Table 4 Percentage of patients that consider consultation aspects 
performed (n = 46)
During the shared medical  
appointment, the health  
care provider…
Performeda Not performedb
n % n %
Examined me 24 52.1 18 39.1
Was friendly 46 100.0 0 0.0
Took me seriously 46 100.0 0 0.0
Listened to what I had to say 44 95.6 0 0.0
Was open to me 43 93.5 1 2.2
Had enough time for me 45 97.8 0 0.0
Was empathic to me 36 78.2 4 8.6
gave me enough attention 45 97.9 0 0.0
gave good information 38 82.6 1 2.2
Notes: aAspects rated as ‘yes’ or ‘actually yes’ are indicated as performed; baspects 
rated as ‘not really’ and ‘no’ are indicated as not performed.
children can relate more to their diabetes nurse, and a pediatri-
cian can answer medical questions. However, a dietician, a child 
psychologist, and a podiatrist may need to be present to answer 
more diverse questions, according to 25% of the parents.
Experiences with SMAs
Experiences of health care providers  
and patients
All but one health care provider indicated satisfaction with 
the SMAs (M = 3.83, SD = 0.62). Most patients (n = 45) 
appeared to be satisfied with the SMA directly after having 
attended the SMA (M = 4.22, SD = 0.81). Their satisfaction 
tended to decrease after 3 months (M = 3.76, SD = 1.15; 
t (28) = 1.94, P = 0.06). Most patients (87%) indicated they 
had learned from fellow patients, fellow patients helped them 
to understand the information better (75%), and they learned 
to ask questions (42%) (Table 6).
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Experiences of parents
According to parents (62.5%), their children enjoy attending 
SMAs to meet other patients with type 1 diabetes. During 
an SMA, patients can discuss each other’s diabetes-related 
problems, learn from their peers, and offer support. Par-
ents (25%) indicated that peers probably enhance patients’ 
knowledge about diabetes. As one parent said: “You never 
know exactly how everything is, unless you have diabetes 
yourself”. Parents differed in opinion about the number and 
duration of SMAs. Some (25%) opted for more frequent 
SMAs, for example once a month, others (37.5%) preferred 
only one SMA a year. SMAs were not experienced positively 
by all. One parent indicated that he/she was not informed 
properly about the purpose of SMAs, which resulted in 
incorrect expectations. SMAs were also valued negatively 
by some parents (25%) when patients are present who do 
not want to participate or when patients do not interact with 
each other. For parents (62.5%), SMAs should preferably be 
attended by patients with similar ages, attitudes, problems, 
and types of insulin treatment. Differences between patients 
are not considered beneficial. One parent stated: “There 
were children aged between 6 and 12 years. This resulted 
in a discussion of general topics while the specific problems 
related to my child’s age were not discussed”. According 
to another parent, age differences result in less interaction, 
because younger children seem too much impressed by the 
stories of adolescents and to not gain any knowledge. Also, 
due to the differences in types of insulin treatments among 
the participants in one SMA, several aspects of insulin treat-
ment were left out of the discussion.
Discussion and conclusion
The aim of this study was to examine the perspectives and 
experiences of health care providers, patients, and parents 
with SMAs for children and adolescents with type 1  diabetes. 
The reasons for participating in SMAs differ between the 
three samples. Health care providers foremost appear to 
have work-related reasons for conducting SMAs, whereas 
patients attend SMAs to share experiences with peers and 
to learn from each other. The parents also value such peer 
relationships and recommend parents not to accompany their 
children to an SMA. However, in most SMAs examined as 
part of this study, parents did accompany their children.
According to the health care providers, more information 
is discussed during SMAs. This viewpoint replicates that 
of a smaller group of health care providers participating in 
the previous study by NIVEL that examined differences in 
diabetes-related topics being discussed during SMAs and 
individual visits.21 The patients did value the extra informa-
tion about lifestyle, a topic considered especially important 
to discuss during SMAs.32,33 However, 46.7% of the patients 
thought that the amount of information provided about 
lifestyle was equal to that in an individual visit. Overall, the 
Table 5 Mean scores of important and performed behavioral 
aspects of health care providers evaluated by patients
The health care provider Important* 
(n = 52) 
M (SD)
Performed* 
(n = 46) 
M (SD)
Examines me 2.67 (0.99) 2.43 (1.60)
Is friendly 3.52 (0.61) 3.98 (0.15)
Takes me seriously 3.67 (0.51) 3.93 (0.25)
Listens to what I have to say 3.56 (0.54) 3.78 (0.84)
Is open to me 3.25 (0.82) 3.76 (0.87)
Has enough time for me 3.23 (0.58) 3.85 (0.63)
Is empathic to me 2.90 (0.99) 3.11 (1.43)
gives me enough attention 3.12 (0.83) 3.89 (0.61)
gives good information 3.46 (0.75) 3.26 (1.45)
Note: *A score ‘1’ indicates not important/performed, a score ‘4’ indicates very 
(much) important/performed.
Abbreviations: M, mean; SD, standard deviation.
Table 6 Patients’ ratings of statements about SMAs
M (SD) Completely 
agree
Agree Neutral Disagree Completely 
disagree
% % % % %
I have learned from fellow patients and their questions 3.98 (0.75) 17.4 69.6 8.7 2.2 2.2
The presence of fellow patients helped me to understand the 
information better
3.75 (0.94) 15.9 59.1 11.4 11.4 2.3
The presence of fellow patients helped me to ask questions 3.11 (1.11) 8.9 33.3 24.4 26.7 6.7
I have experienced support from fellow patients 3.38 (1.13) 11.1 46.7 20.0 13.3 8.9
I have offered support to fellow patients 3.36 (1.04) 9.1 45.5 22.7 18.2 4.5
I liked the presence of several healthcare providers during SMA 3.67 (0.91) 11.1 57.8 22.2 4.4 4.4
The extra time investment for SMA was worthwhile 3.82 (0.98) 20.0 57.8 11.1 6.7 4.4
I would recommend others to participate into SMAs 3.78 (1.04) 24.4 44.4 20.0 6.7 4.4
For the next appointment, I would choose for SMA again 3.55 (1.28) 25.0 36.4 18.2 9.1 11.4
Abbreviations: M, mean; SD, standard deviation; SMAs, shared medical appointments.
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children and adolescents were satisfied about the health care 
providers’ performance during the SMA.
Although health care providers and patients were sat-
isfied with SMAs, patients did show a slight decrease in 
satisfaction with SMAs after 3 months. Post-hoc analyses 
ruled out the possibility that only dissatisfied patients filled 
in the 3-month questionnaire. In addition, the added value 
of SMA remains apparent as most patients would recom-
mend SMAs to others and would choose SMA for their 
next appointment. Parents differed in their satisfaction with 
SMAs. Some were negative because they had expected 
something else, others were positive because their child 
enjoyed attending SMAs. The time investment for SMA 
was no barrier for patients, but some parents were more 
reluctant about this.
Limitations and recommendations
This study applied a data-sources triangulation of perspec-
tives from health care providers, patients and parents using 
two different data-collection methodologies.24 The latter 
made it somewhat difficult to compare parents’ reactions 
from the OFG with the items of the questionnaires completed 
by the health care providers and the patients, even though 
both methods did assess the same topics. However, the OFG 
gave a more comprehensive view of the experiences of par-
ents as they had the ability to explain certain perspectives, 
whereas health care providers and patients could only rate 
their perspectives on the questionnaires.
Another limitation of this study is the examination of 
participants’ perspectives with only one SMA. More experi-
ences with SMAs may lead to different results. It could also 
help to investigate health-related outcomes (eg, HbA
1c
 levels) 
of SMAs in children and adolescents with type 1 diabetes as 
only few studies are known that investigate pediatric SMAs 
in diabetes care.20,21
Furthermore, the sample of SMAs, patients, parents, and 
providers was rather small and therefore not representative. 
Further research is necessary among a larger and repre-
sentative sample, and participants who attended multiple 
SMAs.
Parents indicated that SMAs should be attended by 
patients with similar ages, treatments and problems. Group 
visits have indeed shown to be more effective with older 
adolescents than with younger ones.20 Parents also indicated 
that their own presence might have resulted in less interac-
tion and less disclosure of experienced problems among the 
children. This loss of the child’s perspective when parents 
are present is also reflected in a study by Dedding.8
Future studies should therefore examine the effects of 
differences between patients, the presence of parents, and 
that of different health care providers. This may result in a 
standardized format for SMAs that is tailored to patients’ 
age and other patient characteristics or needs.
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Appendix 1 
What are (protocolized11) shared medical 
appointments?
Shared medical appointments (SMAs) were first introduced 
in the United States in 199617 and later in the  Netherlands.11 
During an SMA between five to eight  (chronically ill) patients 
attend their physician  simultaneously to discuss (their) 
health care and related issues during a visit of approximately 
90 minutes. The physician approached the patients one-by-
one in the presence of the rest of the group, thereby providing 
the same care as during a traditional  individual appointment. 
The physician is assisted by a  professional group leader 
(moderator) and a medical assistant or nurse practitioner. 
The formation of this multidisciplinary care team depends 
on the patient’s illness.11
The group setting is expected to stimulate active interac-
tion by asking questions and allowing for interruptions to take 
place.17 It is the role of the moderator to explain the proce-
dure of the SMA, stress confidentiality, invite participants 
to respond, and let everybody speak and have their turn. In 
case of SMAs in diabetes, a medical assistant or nurse practi-
tioner is present to measure weight, height, and glycosylated 
hemoglobin levels, and to register relevant symptoms and 
make follow-up appointments.14 The agenda of an SMA 
is not decided beforehand. The moderator is instructed to 
highlight shared topics that arise when individual patients 
are approached by the physician one by one.
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